Spectral Medical Inc.

TSX:EDT.TO

Medical - Diagnostics & Research

Healthcare
$1.04 -1.45%

-$0.02 today

Market cap
$306.00M
Beta
0.23
P/E (TTM)
-10.5
EPS (TTM)
-$0.13
52W Low $0.77High $1.84

Volume 0.02M

Average 0.06M

EDT.TO Income Before Tax

Profit after all operating and non-operating items but before income tax.

Spectral Medical Inc.TSX: EDT.TO

Income Before Tax · Q1 FY2026 · quarter ended Mar 2026

Income before tax remains negative

Q1 FY2026 income before tax was -CA$2.94M, compared with -CA$12.6M a year earlier. Trailing-twelve-month income before tax was -CA$38.02M.

Context

  • Income before tax amounted to 1952.9% of revenue in FY2025, up 1279.4 pp from a year earlier.
  • Income before tax grew in size in 2 of the last 3 fiscal years.
  • FY2025 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly income before tax holds near -CA$2.94M or moves back toward the trailing-twelve-month quarterly average of -CA$9.51M.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
-CA$2.94M-3.5% QoQ
Last fiscal yearDec 2025
-CA$47.69M-209.8% YoY
LTMMar 2026
-CA$38.02M-59.5% YoY
Income Before Tax past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+76.7%——
1 year-209.8%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Income Before Tax history

CAD · from the income statement

Latest · FY2025
(47.69M) CAD
Year-over-year change
-209.8%

Income Before Tax vs competitors

How EDT.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so income before tax is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -59.5% is the 7th highest of 8, against a peer median of +10.5%.
  • Income before tax amounts to 1377.1% of revenue for EDT.TO, versus a peer median of 28.5%.
EDT.TO Competitors
Income Before Tax for EDT.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ACB.TOAurora Cannabis Inc.LTM Mar 2026CA$22.52M CAD+10.5%—7.1%
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 2026$20.21M USD+978.7%+15.0%39.7%
KSI.TOKneat.com, Inc.LTM Mar 2026-CA$8.22M CAD-302.1%—12.4%
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026-$8.81M USD+37.4%—17.2%
EDT.TOSpectral Medical Inc.LTM Mar 2026-CA$38.02M CAD-59.5%—1377.1%
PRN.TOProfound Medical Corp.LTM Mar 2026-$38.59M USD-19.3%—205.7%
EPRX.TOEupraxia Pharmaceuticals Inc.LTM Mar 2026-$42.19M USD-41.0%——
WEED.TOCanopy Growth CorporationLTM Mar 2026-CA$263.45M CAD+55.9%—84.7%
Peer median (excluding EDT.TO) —+10.5%+15.0%28.5%

Competitors are the stored peer set for EDT.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2M1.67M1.6M2.29M2.44M
Cost of Revenue832K684K936K1.27M7.6M
Gross Profit1.16M983K662K1.02M(5.16M)
Gross Margin58.3%59.0%41.4%44.5%-211.1%
Research & Development004.68M3.97M4.33M
Selling, General & Admin7.01M8.64M11.29M11.62M11.73M
Operating Expenses7.86M9.43M12.08M13.02M6.53M
Depreciation & Amortization294K272K218K251K250K
EBITDA(6.38M)(7.18M)(13.96M)(11.97M)(11.44M)
EBITDA Margin-319.4%-430.7%-873.3%-523.5%-468.3%
Operating Income(6.66M)(8.45M)(11.42M)(12M)(11.69M)
Operating Margin-333.5%-506.7%-714.7%-524.8%-478.5%
Interest Income00005.39M
Interest Expense28K176K1.33M3.18M5.16M
Other Income / Expenses(40K)819K(4.09M)(3.4M)(36M)
Income Before Tax(6.96M)(7.63M)(15.51M)(15.4M)(47.69M)
Pre-Tax Margin-348.6%-457.6%-970.4%-673.4%-1952.9%
Income Tax Expense00000
Net Income(8.79M)(11.28M)(15.66M)(15.4M)(47.69M)
Net Margin-440.1%-676.7%-980.1%-673.8%-1953.0%
EPS (Basic)(0.03)(0.04)(0.06)(0.05)(0.17)
EPS (Diluted)(0.03)(0.04)(0.06)(0.05)(0.17)
Weighted Avg Shares252.46M269.84M278.56M281.08M287.21M
Weighted Avg Shares (Diluted)252.46M269.84M278.56M281.08M287.21M

Spectral Medical Inc.

TSX:EDT.TO

Intrinsic Alpha fair value

Locked

Current Price

$1.04

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.